Anthony MCKINNEY,Brian MCMILLAN,Matthew GREENE,Walter PISKORSKI
申请号:
US15102949
公开号:
US20160303077A1
申请日:
2014.12.09
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Provided are pharmaceutical compositions comprising (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form. The compositions are formulated for providing a sustained release of enantiomerically pure (1R,5S)-1-(naphthalene-2-yl)-3-azabicyclo[3.1.0]hexane. The compositions are substantially free of the other (−) enantiomer of the compound.